Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1201-1204, 2004. First published May 13, 2004; 10.1373/clinchem.2004.032938
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.032938v1
50/7/1201    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, M. Y.
Right arrow Articles by Arnett, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, M. Y.
Right arrow Articles by Arnett, D. K.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2004;50:1201-1204.)
© 2004 American Association for Clinical Chemistry, Inc.


Lipids, Lipoproteins, and Cardiovascular Risk Factors

Comparison of Ultracentrifugation and Nuclear Magnetic Resonance Spectroscopy in the Quantification of Triglyceride-Rich Lipoproteins after an Oral Fat Load

Michael Y. Tsai1,a, Angeliki Georgopoulos1, James D. Otvos2, Jose M. Ordovas3, Naomi Q. Hanson1, James M. Peacock4 and Donna K. Arnett4

1 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN. 2 Liposcience, Raleigh, NC. 3 US Department of Agriculture-Human Nutrition Research Center on Aging at Tufts University, Boston, MA. 4 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN.

aAddress correspondence to this author at: 420 Delaware St. SE, Mayo Mail Code 609, Minneapolis, MN 55455-0392. Fax 612-625-5622; e-mail tsaix001{at}tc.umn.edu.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: The measurement of triglyceride (TG)-rich particles after an oral fat challenge has been used to provide a measure of risk for coronary artery disease independent of the fasting plasma triglyceride concentration. The analytical "gold standard" for measuring TG-rich lipoproteins uses density gradient ultracentrifugation; however, this technique is labor-intensive. Because of our need to perform numerous postprandial analyses of TG-rich lipoproteins for a large interventional study (Genetics of Lipid Lowering Drugs and Diet Network), we evaluated the use of nuclear magnetic resonance (NMR) spectroscopy for measuring TG-rich particles.

Methods: EDTA-blood samples were obtained 0, 3.5, 6, and 8 h after ingestion of an oral fat meal (89% of calories from fat) in 20 apparently healthy individuals. The plasma TG concentrations of chylomicron and chylomicron remnant/VLDL fractions were analyzed by ultracentrifugation and NMR spectroscopy.

Results: Comparison of all values (n = 78) by ultracentrifugation (x) and NMR (y) produced a linear regression equation of y = 0.979x – 0.035 mmol/L (R2 = 0.90) for chylomicrons and y = 1.398x + 0.067 mmol/L (R2 = 0.96) for the fraction containing chylomicron remnants and VLDL. Postprandial response of chylomicrons and chylomicron remnant/VLDL was similar, with maximum response occurring between 3.5 to 6 h regardless of method of measurement.

Conclusion: Chylomicron and chylomicron remnant/VLDL fraction measurements obtained by NMR have a high degree of correlation with results produced by ultracentrifugation. NMR may therefore be suitable as an alternative method for the measurement of postprandial TG-rich lipoproteins in individuals consuming a high-fat meal.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Several experimental and observational studies have demonstrated that concentrations of triglyceride (TG)-rich lipoproteins, such as remnants of chylomicrons and VLDL, are associated with the progression of atherosclerosis (1)(2)(3). To determine an individual’s ability to clear postprandial lipids, TG-rich particles can be measured after an oral fat loading. The resulting concentration of TG-rich lipoproteins is thought to correlate with an individual’s risk of coronary artery disease that is independent of the fasting plasma TG concentration.

The analytical "gold standard" for measuring TG-rich lipoproteins uses density gradient ultracentrifugation(4)(5). This technique is labor-intensive and involves a 24-h analysis to fractionate the plasma lipoproteins. Moreover, only a few samples can be processed at the same time in each ultracentrifuge, precluding use of this method in studies with large numbers of samples. An immunochemical method (Japan Immunoresearch Laboratories) has also been used to isolate remnant-like particles(6)(7).

Recently, nuclear magnetic resonance (NMR) spectroscopy has been used to quantify subspecies of VLDL, LDL, and HDL(8)(9). The NMR method uses characteristic signal amplitudes of the lipoprotein subclasses of different sizes as its basis of quantification. Although the data produced by NMR analysis have been primarily of interest in determining the proportion of large vs small LDL, NMR analysis can simultaneously provide data for the quantification of all lipoprotein classes, potentially including chylomicron and chylomicron remnant/VLDL fractions in postprandial samples. To date, there has not been a published report comparing the measurement of TG-rich particles by NMR with results obtained by classic ultracentrifugation.

In the Genetics of Lipid Lowering Drugs and Diet Network study, we have proposed determining the genetic basis of the variable response to fenofibrate, a drug used primarily for the lowering of serum TG concentrations. One of the objectives of the Genetics of Lipid Lowering Drugs and Diet Network study is to assess postprandial response to a high-fat meal by quantifying TG-rich lipoproteins at different time points after a fat challenge. We intend to recruit 1200 individuals and assess the postprandial response both before and after fenofibrate treatment. Thus, it is desirable to have a postprandial analysis technique that is less labor-intensive and has a faster turnaround time than density gradient ultracentrifugation. In the current study, we present the results of a pilot study in which we compared values for TG-rich particles obtained by NMR with those obtained by density gradient ultracentrifugation on 20 individuals who had blood samples drawn after a 10-h fast and at 3.5, 6, and 8 h after an oral fat challenge meal.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
study population
We studied 20 apparently healthy individuals [7 males and 13 females; age range, 25–70 years, mean (SD) age, 44.8 (13.3) years]. All participants were instructed to fast for at least 10 h and to abstain from strenuous exercise and alcohol consumption for at least 3 days before participation in this study. This study was approved by the Human Studies Committee of the University of Minnesota Institutional Review Board, and all participants gave informed consent.

experimental design
Fasting blood samples for lipoprotein analysis were collected in EDTA-containing tubes. Immediately after the fasting sample was collected, participants were fed a high-fat test meal according to the protocol of Patsch et al. (10). The typical test meal consisted of 175 mL of heavy whipping cream (39.5% fat), 1 tablespoon of chocolate-flavored syrup, and 0.5 tablespoon instant nonfat dry milk. Participants were instructed to consume the "shake" within 15 min. The meal contained 700 calories/m2 of body surface area (3% derived from protein, 14% from carbohydrate, and 83% from fat) with a cholesterol content of 240 mg and a ratio of polyunsaturated to saturated fat of 0.06. Participants were allowed to return to work but were instructed to take nothing by mouth except water or unsweetened black coffee or tea and to abstain from strenuous physical work or exercise until the postprandial lipoprotein blood samples were obtained. Postprandial lipoprotein samples were collected in EDTA-containing tubes 3.5, 6, and 8 h after ingestion of the high-fat meal. An 8 h specimen was unavailable on one participant, and a 0 h specimen was unavailable for NMR on a second participant; therefore, the final number of values available for comparison by ultracentrifugation and NMR was 78.

assay procedures
The fasting and 3.5, 6, and 8 h postprandial lipoprotein samples were centrifuged within 20 min of collection at 2000g for 15 min at 4 °C. Plasma samples were stored at 4 °C, and all analyses were performed within 4 days of collection.

TGs were measured by a glycerol-blanked enzymatic method (Triglyceride GB reagent; Roche Diagnostics Corporation) on the Roche COBAS FARA centrifugal analyzer (Roche Diagnostics Corporation).

Chylomicrons, as well as remnants of chylomicrons and VLDL, were isolated by salt density gradient ultracentrifugation according to the method of Lindgren et al. (4) as modified by Redgrave and Carlson (5). We used ultracentrifugation with a SW 41 rotor to separate two fractions: Sf >400 (4.5 x 106 g · min), containing chylomicrons, and Sf 20–400 (147.5 x 106 g · min), containing chylomicron remnants and VLDL. Because 90% of the chylomicron fraction by weight consisted of TGs, the concentrations of chylomicrons and chylomicron remnants/VLDL were measured in each fraction in terms of its TG concentration. The TG concentration was adjusted for the amount of plasma initially used and the amount of supernatant collected during ultracentrifugation.

The TG concentrations in the chylomicron and chylomicron remnant/VLDL fractions were measured by proton NMR spectroscopy on nonfractionated plasma (Liposcience). This method quantifies particle concentration by converting the characteristic signal amplitude generated by the methyl group NMR signal of each lipoprotein subclass particle (9).

statistical analysis
Least-squares linear regression analysis was used to compare concentrations of chylomicron and chylomicron remnant/VLDL fractions obtained by ultracentrifugation and NMR spectroscopy methods (Pearson, Microsoft Excel 2000). Ultracentrifugation was used as the independent variable; NMR was the dependent variable. The paired Student t-test was used to compare the mean TG concentration as measured by each method and to determine significant differences (SPSS, Ver. 10.0). Significance was defined as P <0.05.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Shown in Fig. 1 is a comparison of the concentrations of chylomicron and chylomicron remnant/VLDL fractions obtained by ultracentrifugation (x) with values obtained by NMR spectroscopy (y) at 0, 3.5, 6, and 8 h after an oral fat loading for 20 individuals. Comparison of chylomicron fractions produced the following linear regression equation: y = 0.979x – 0.035 mmol/L (R2 = 0.90). NMR produced significantly (P = 0.01) lower [mean (SE), 0.43 (0.05) mmol/L TGs] results for the chylomicron fraction compared with ultracentrifugation [0.48 (0.05) mmol/L TGs]. Conversely, mean values for the chylomicron remnant/VLDL fraction measured by NMR were significantly (P <0.001) higher [1.07 (0.94) mmol/L TGs] compared with mean values obtained by ultracentrifugation [0.72 (0.66) mmol/L TGs]. Comparison of chylomicron remnants/VLDL by ultracentrifugation and NMR spectroscopy produced the following linear regression equation: y = 1.398x + 0.067 mmol/L, with excellent correlation between the two methods (R2 = 0.96).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Comparison of TG concentration in chylomicron (top panel) and chylomicron remnant/VLDL (bottom panel) fractions by ultracentrifugation (x) vs NMR spectroscopy (y) on 78 samples.

Dashed lines indicate lines of perfect correlation. Results of linear regression analysis: chylomicrons (top panel), y = 0.9791x – 0.035 mmol/L (R2 = 0.8994; Sy|x = 0.16 mmol/L); chylomicron remnant/VLDL, y = 1.3976x + 0.0674 mmol/L (R2 = 0.9579; Sy|x = 0.17 mmol/L).

As shown in Fig. 2 , the postprandial response of chylomicrons, expressed as the mean difference from 0 h, was similar when measured by ultracentrifugation and NMR, with the peak response between 3.5 and 6 h. No significant differences in postprandial response were observed at any time interval. With regard to chylomicron remnants/VLDL, the peak response was at 3.5 h when measured by either ultracentrifugation or NMR. No differences in response were observed except at 6 h (P <0.05).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Postprandial response of TG concentration of chylomicron (top panel) and chylomicron remnant/VLDL (bottom panel) fractions, expressed as the mean difference from 0 h, by ultracentrifugation ({blacktriangleup}) and NMR ({blacksquare}).

*, P <0.05 for the difference between ultracentrifugation and NMR methods in the chylomicron remnant/VLDL fraction. Error bars represent the SE of each data point. The number of individuals at each time point were as follows: 0 h, n = 19; 3.5 h, n = 20; 6 h, n = 20; 8 h, n = 19.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The interest in NMR as a method for the analysis of lipoproteins has to date been largely restricted to its usefulness in determining the size of lipoprotein subspecies. In particular, the major focus has been on LDL particles (11)(12)(13). In fact, when a sample is subjected to NMR analysis, information on all lipoprotein particles, including quantification of the chylomicron and chylomicron remnant/VLDL fractions, becomes available simultaneously. However, although NMR can theoretically provide quantification of TG-rich lipoproteins, to our knowledge no study has validated whether NMR provides reliable results for the quantification of TG-rich lipoproteins, especially after a fat-loading meal.

In the current study, we showed that, based on TG concentration, the results from NMR analysis and ultracentrifugation separation had a high degree of correlation with respect to either the chylomicron fraction or the chylomicron remnant/VLDL fraction. NMR gave lower values for chylomicrons and higher values for chylomicron remnants/VLDL compared with ultracentrifugation. The exact reason for this difference is not known. However, it should be noted that chylomicrons defined by the two methods may not comprise exactly the same population of particles because one (ultracentrifugation) is defined by flotation rate and the other (NMR) by particle diameter. Nevertheless, the high correlation between these two methods suggests that NMR can be considered as an alternative method for the quantification of TG-rich lipoproteins in nonfasting states. Compared with ultracentrifugation, NMR is a more rapid procedure and uses substantially less sample volume than traditional ultracentrifugation. Moreover, it provides information not only on TG-rich lipoproteins but also on the quantities and the relative sizes of both LDL and HDL particles. In addition, because NMR is a physical rather than a chemical procedure, plasma samples subjected to NMR analysis can be preserved for biochemical assays of stable analytes. However, NMR is a relatively new method and is not widely available at present.

In summary, our study comparing NMR with density gradient ultracentrifugation shows that the results obtained by NMR have a high degree of correlation with results produced by ultracentrifugation. Therefore, NMR can be considered as an alternative method for the measurement of postprandial TG-rich lipoproteins in individuals, particularly in studies involving large numbers of participants.


   Acknowledgments
 
Support was provided in part by the National Heart, Lung, and Blood Institute Cooperative Agreement Grants U01 HL72524-01, HL72524-02, HL72524-03, and HL72524-04, and internal funds from the Division of Epidemiology at the University of Minnesota School of Public Health. We wish to thank the following staff: Greg Feitl, Kim Weis, Ed Bader, Brandi Lesnar, Melissa Zaffke, Laura Salvati, Jean Bucksa, Valerie Arends, and Greg Rynders.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999;246:341-355.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  2. Hodis HN. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis [Editorial; Comment]. Circulation 1999;99:2852-2854.[Free Full Text]
  3. Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998;81:13B-17B.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  4. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. Nelson GF eds. Blood lipids and lipoproteins 1972:181-274 Wiley New York. .
  5. Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic men. J Lipid Res 1979;20:217-229.[Abstract]
  6. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PF, Ordovas JM, et al. Remnant lipoprotein cholesterol and triglyceride: reference ranges from the Framingham Heart Study. Clin Chem 1998;44:1224-1232.[Abstract/Free Full Text]
  7. Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002;90:689-696.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  8. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992;38:1632-1638.[Abstract/Free Full Text]
  9. Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Rifai N Warnick GR Dominiczak MN eds. Handbook of lipoprotein testing, 2nd ed 2000:609-623 AACC Press Washington, DC. .
  10. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-1345.[Abstract/Free Full Text]
  11. Blake GJ, Otvos JD, Rifai N, Ridker PM. LDL particle concentration and size as determined by NMR spectroscopy as predictors of cardiovascular disease in women. Circulation 2002;106:1930-1937.[Abstract/Free Full Text]
  12. Rosenson RS, Freedman DS, Otvos JD. Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC I trial. Am J Cardiol 2002;90:89-94.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  13. Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, et al. NMR spectroscopy of lipoproteins and risk of CHD in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2002;22:1175-1180.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
J. Nutr.Home page
M. Junyent, D. K. Arnett, M. Y. Tsai, E. K. Kabagambe, R. J. Straka, M. Province, P. An, C.-Q. Lai, L. D. Parnell, J. Shen, et al.
Genetic Variants at the PDZ-Interacting Domain of the Scavenger Receptor Class B Type I Interact with Diet to Influence the Risk of Metabolic Syndrome in Obese Men and Women
J. Nutr., May 1, 2009; 139(5): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Warodomwichit, D. K. Arnett, E. K. Kabagambe, M. Y. Tsai, J. E. Hixson, R. J. Straka, M. Province, P. An, C.-Q. Lai, I. Borecki, et al.
Polyunsaturated Fatty Acids Modulate the Effect of TCF7L2 Gene Variants on Postprandial Lipemia
J. Nutr., March 1, 2009; 139(3): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Perez-Martinez, D. Corella, J. Shen, D. K Arnett, N. Yiannakouris, E S. Tai, M. Orho-Melander, K. L Tucker, M. Tsai, R. J Straka, et al.
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 391 - 399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Perez-Martinez, N. Yiannakouris, J. Lopez-Miranda, D. Arnett, M. Tsai, E. Galan, R. Straka, J. Delgado-Lista, M. Province, J. Ruano, et al.
Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 744 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X.-Y. Zheng and L. Liu
Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase
J. Lipid Res., August 1, 2007; 48(8): 1673 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C.-Q. Lai, D. K. Arnett, D. Corella, R. J. Straka, M. Y. Tsai, J. M. Peacock, X. Adiconis, L. D. Parnell, J. E. Hixson, M. A. Province, et al.
Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants: The GOLDN Study
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1417 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Corella, D. K. Arnett, M. Y. Tsai, E. K. Kabagambe, J. M. Peacock, J. E. Hixson, R. J. Straka, M. Province, C.-Q. Lai, L. D. Parnell, et al.
The -256T>C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study
Clin. Chem., June 1, 2007; 53(6): 1144 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. D. Knuth and J. F. Horowitz
The Elevation of Ingested Lipids within Plasma Chylomicrons Is Prolonged in Men Compared with Women
J. Nutr., June 1, 2006; 136(6): 1498 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. H. Stein, M. A. Merwood, J. B. Bellehumeur, P. E. McBride, D. A. Wiebe, and J. M. Sosman
Postprandial Lipoprotein Changes in Patients Taking Antiretroviral Therapy for HIV Infection
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 399 - 405.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.032938v1
50/7/1201    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, M. Y.
Right arrow Articles by Arnett, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, M. Y.
Right arrow Articles by Arnett, D. K.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS